Enbrel Sales Data
| Rank 6 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Enbrel U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 6 ( 1) |
$1,189,844 | 1.46% | 954 | -1.14% |
| Q3 2013 | 7 | $1,172,679 | 2.16% | 965 | -4.55% |
| Q2 2013 | 7 | $1,147,929 | 6.76% | 1,011 | 4.33% |
| Q1 2013 | 7 | $1,075,249 | -1.22% | 969 | -6.83% |
| Q4 2012 | 7 | $1,088,533 | 2.05% | 1,040 | 4.52% |
| Q3 2012 | 7 (1) |
$1,066,697 | 12.51% | 995 | 13.33% |
| Q2 2012 | 8 (4) |
$948,119 | 6.51% | 878 | 6.68% |
| Q1 2012 | 12 ( 1) |
$890,135 | 1.92% | 823 | -4.63% |
| Q4 2011 | 11 (1) |
$873,343 | 1.67% | 863 | 1.77% |
| Q3 2011 | 12 (1) |
$858,997 | 1.27% | 848 | -2.97% |
| Q2 2011 | 13 (2) |
$848,230 | 3.77% | 874 | 3.19% |
| Q1 2011 | 11 | $817,401 | n/a | 847 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
